| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Nippon India Nifty Pharma ETF |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.20 |
| Equity |
99.78 |
| Trep |
0.02 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
54.73% |
| Top 10 Holdings |
78.95% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
99.78 |
| Cash |
0.22 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.82 |
| PE Ratio |
38.04 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Ltd. |
21.29 |
| Divis Laboratories Ltd. |
10.34 |
| Cipla Ltd. |
8.37 |
| Torrent Pharmaceuticals Ltd. |
7.59 |
| Laurus Labs Limited |
7.14 |
| Dr. Reddys Laboratories Ltd. |
7.07 |
| Lupin Ltd |
5.93 |
| Aurobindo Pharma Ltd. |
4.42 |
| Glenmark Pharmaceuticals ltd |
3.40 |
| Alkem Laboratories Limited |
3.40 |
| Biocon Ltd. |
3.07 |
| Zydus Lifesciences Limited |
2.85 |
| Mankind Pharma Limited |
2.82 |
| Ipca Laboratories Ltd. |
2.45 |
| Gland Pharma Limited |
2.02 |
| Sai Life Sciences Limited |
1.83 |
| Wockhardt Ltd |
1.63 |
| Ajanta Pharma Ltd. |
1.47 |
| Abbott India Ltd. |
1.46 |
| PIRAMAL PHARMA LIMITED |
1.23 |
| Net Current Assets |
0.20 |
| Triparty Repo |
0.02 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|